Polaris AI Pharma Corp. (KOSDAQ:041910)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,390.00
-320.00 (-4.77%)
At close: May 29, 2026
Market Cap84.88B +9.0%
Revenue (ttm)63.94B +8.7%
Net Income989.48M -92.8%
EPS84.72 -92.8%
Shares Out 13.28M
PE Ratio75.43
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume147,823
Open6,710.00
Previous Close6,710.00
Day's Range6,380.00 - 6,820.00
52-Week Range5,800.00 - 10,200.00
Beta0.54
Analystsn/a
Price Targetn/a
Earnings Daten/a

About Polaris AI Pharma

Polaris AI Pharma Corp. engages in the manufacture and sale of pharmaceuticals products in South Korea and internationally. It also offers its products for various therapeutic categories, such as diagnostic acid, antidiabetic, anti-depressants, and cholinergic. The company was formerly known as EstechPharma Co., Ltd. and changed its name to Polaris AI Pharma Corp. in March 2024. The company was founded in 1996 and is headquartered in Hwaseong-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 161
Stock Exchange KOSDAQ
Ticker Symbol 041910
Full Company Profile